Pro-inflammatory cytokines predominate in the brains of dogs with visceral leishmaniasis: A natural model of neuroinflammation during systemic parasitic infection  by Melo, Guilherme D. et al.
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Visceral  leishmaniasis  is  a multisystemic  zoonotic  disease  that  can  manifest  with  several
symptoms,  including  neurological  disorders.  To  investigate  the  pathogenesis  of brain  alter-
ations occurring  during  visceral  leishmaniasis  infection,  the expression  of  the  cytokines
IL-1, IL-6,  IL-10,  IL-12p40,  IFN-,  TGF-  and  TNF-  and  their correlations  with  peripheral
parasite  load  were  evaluated  in  the  brains  of  dogs  naturally  infected  with  Leishmania  infan-
tum. IL-1,  IFN-  and  TNF-  were  noticeably  up-regulated,  and  IL-10,  TGF-  and  IL-12p40
were  down-regulated  in  the  brains  of infected  dogs.  Expression  levels  did not  correlateentral nervous system
mmune system
nﬂammation
eishmania infantum
T-qPCR
with  parasite  load  suggestive  that  the  brain  alterations  are  due to  the  host’s  immune
response  regardless  of  the  phase  of the  disease.  These  data  indicate  the  presence  of  a pro-
inﬂammatory  status  in  the nervous  milieu  of dogs  with  visceral  leishmaniasis  especially
because  IL-1  and  TNF-  are  considered  key  factors  for the  initiation,  maintenance  and
persistence  of  inﬂammation.. Introduction
Leishmaniasis is a complex disease caused by more
han 20 different species of protozoans of the Leishmania
enus (Kinetoplastida, Trypanosomatidae). Leishmaniasis
s transmitted by over 30 distinct phlebotomine sand
ies and has four different types of clinical presenta-
ion: visceral leishmaniasis (VL), cutaneous leishmaniasis,
uco-cutaneous leishmaniasis, and post-kala-azar der-
al  leishmaniasis (PKDL). Leishmaniasis is an important
ause of human death, among the parasitic diseases it is
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surpassed only by malaria (Chappuis et al., 2007). VL, also
known as kala-azar, is an anthropozoonosis caused by the
Leishmania donovani complex: L. infantum (Syn. chagasi) in
the Americas and in the Mediterranean basin, and L. dono-
vani in Asia and Africa (Baneth et al., 2008; Lukesˇ et al.,
2007; Mauricio et al., 2000).
In addition to the skin, VL affects mainly the organs
with cells of the mononuclear phagocyte system, such
as the spleen, lymph nodes, liver, bone marrow. The
typical histopathological ﬁnding is granulomatous inﬂam-
matory reaction associated with the presence of Leishmania
amastigotes within macrophages (Alvar et al., 2004; Baneth
et al., 2008). Although there are several reports of the sys-
temic symptoms of VL, such as fever, anemia, weight loss,
Open access under the Elsevier OA license.skin disease, and renal and ocular alterations (Alvar et al.,
2004; Blavier et al., 2001; Ciaramella and Corona, 2003;
Moreno et al., 1998), few studies have related the occur-
rence of injuries in the central nervous system (CNS).
ry Parasi
coefﬁcients (slopes) were obtained from ampliﬁcation of
seven serial dilutions of a pool of cDNA. Quantiﬁcation of58 G.D. Melo et al. / Veterina
In humans, the involvement of the peripheral nervous
system in VL is more usual than the involvement of the
CNS (Snydman et al., 2006). Hashim et al. (1995) reported
that 46% of patients with VL presented neurological symp-
toms, most of them describing the sensation of burning
feet. In addition to peripheral neuropathy, there are reports
of alterations similar to those in Guillain–Barré syn-
drome, cranial nerve dysfunction and meningitis (Snydman
et al., 2006). Dogs with VL may  present signs of gen-
eralized CNS involvement, with seizures, cranial nerve
alterations, vestibular and cerebellar signs, motor incoor-
dination, tetraparesis and tetraplegia, and myoclonia (Font
et al., 2004; Ikeda et al., 2007; José-López et al., 2012;
Melo et al., 2012). The main histopathological alterations
in the brains of these dogs are meningitis and choroiditis,
which are mainly secondary to antigen and immunoglob-
ulin deposition and leukocyte inﬁltration (Garcia-Alonso
et al., 1996; Ikeda et al., 2007; Melo et al., 2009; Melo and
Machado, 2009, 2011; Nieto et al., 1996; Vin˜uelas et al.,
2001).
VL is an immunomediated disease, and studies have
demonstrated a failure of the cellular response in symp-
tomatic dogs that is characterized by a diminishment of
the lymphoproliferative response against Leishmania anti-
gens and a decrease in the number of CD4+ T lymphocytes
(Pinelli et al., 1999; Solano-Gallego et al., 2000). In infected
but clinically healthy dogs, the Th1 immune response pre-
vails and is mediated by IL-2, IFN- and TNF-. This is
in contrast to symptomatic animals, in which cytokines
such as IL-4, IL-10 and TGF- mediate the Th2 response
(Barbiéri, 2006; Reis et al., 2009; Solano-Gallego et al.,
2011; Strauss-Ayali et al., 2005). Nevertheless, immune
response polarization is not a rule during Leishmania infec-
tion due to the role of regulatory T cells (Treg), which
suppress the immune response by means of cell-cell inter-
actions and/or production of suppressor cytokines, such as
IL-10 and TGF-, which render Th0 the immune response
against Leishmania (Belkaid et al., 2002; Campanelli et al.,
2006; Gantt et al., 2003).
In view of the paucity of available data relating VL to the
CNS and because the presence of cytokines in the nervous
milieu may  indicate an inﬂammatory environment, the
aims of this study were to determine the gene expression of
the pro-inﬂammatory cytokines IL-1, IL-6, IL-12p40, IFN-
 and TNF- and the anti-inﬂammatory cytokines IL-10 and
TGF- in the brains of dogs naturally infected with VL and
to determine the correlation between the brain cytokine
proﬁle and the peripheral parasite load.
2. Materials and methods
2.1. Animals
Twenty-ﬁve dogs, 13 male and 12 female, ranging in age
from 1 to 6 years old that were referred to the Veterinary
Teaching Hospital of UNESP, São Paulo State University in
Arac¸ atuba, São Paulo State, Brazil were included in this
study. Nineteen naturally infected dogs, which were euth-
anized with the owners’ permissions, in compliance with
state law (São Paulo, 2006), as soon as the VL diagnosis
was conﬁrmed were included in the infected group, andtology 192 (2013) 57– 66
six uninfected healthy dogs, with no underlying condition
and whose deaths had no sign of nervous involvement
(e.g. trauma) were included in the control group. VL diag-
nosis was achieved using a routine ELISA (enzyme-linked
immunosorbent assay) according to Lima et al. (2005).
None of these animals were previously vaccinated against
CVL. The animals were also negative for toxoplasmosis and
neosporosis, as assessed by indirect immunoﬂuorescence
assays.
2.2. Sampling
Blood samples were collected, and the dogs were euth-
anized with an overdose of pentobarbital (Nembutal®) and
potassium chloride. Necropsies were performed imme-
diately after euthanasia, and macroscopic lesions were
recorded. Brains were collected and separated into two
hemispheres; one of which was placed in 10% buffered-
formalin, and fragments of 0.5 cm3 from the thalamus,
hippocampus, piriform/temporal cortex and periventricu-
lar white matter were collected from the other hemisphere
and stored in RNAlater (Applied Biosystems, AM7020) and
frozen at −80 ◦C. Fragments of 2 cm3 of spleen were also
collected and immediately frozen at −80 ◦C.
2.3. Brain cytokine quantiﬁcation by RT-qPCR
Total RNA was  extracted from the brain samples stored
in RNAlater weighing ca. 100 mg  using the RiboPure kit
(Applied Biosystems, AM1924) according to the manu-
facturer’s protocol. After RNA extraction, any potential
contaminating DNA was removed by incubation with
DNAse I (Applied Biosystems, AM1928) at 37 ◦C for 30 min.
Next, RNA was quantiﬁed with a NanoDrop spectropho-
tometer (260/280 ratio between 2.0 and 2.3) and frozen
at −80 ◦C until the reverse transcription reaction was
preformed. cDNA production was  achieved using the RET-
ROscript kit (Applied Biosystems, AM1710) with 1000 ng of
RNA and oligo(dT) primers in a ﬁnal volume of 20 L and
cycled at 44 ◦C for 1 h and 92 ◦C for 10 min. Then, the cDNA
was  frozen at −20 ◦C until further analyses. Speciﬁc canine
primers and hydrolysis probes for amplifying cytokines
were selected based on the scientiﬁc literature (IL-1, IL-
6, IL-10, IL-12p40, IFN- and TGF-) or designed (TNF-
)  using the on-line software Primer3Plus1 (Untergasser
et al., 2007). The hydrolysis probes were labeled with the
reporter dye FAM at the 5′ end, and with the quencher
dye BHQ-1 at the 3′ end (Table 1). qPCR was carried out
in a real-time thermocycler (Bio-Rad, CFX96) using Taq-
Man  Master Mix  (Applied Biosystems, 4304437), 400 nM of
each primer, 250 nM of the probe and 5 L of cDNA in a total
volume of 25 L. The ampliﬁcation conditions were as fol-
lows: 55 ◦C for 2 min, 95 ◦C for 10 min, 45 cycles of 95 ◦C for
15 s and 60 ◦C for 1 min. For each cytokine, values of reac-
tion efﬁciency, determination coefﬁcients (r2) and angulargene expression was  performed by the 2−Ct method
1 http://www.primer3plus.com.
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Table 1
Primer (forward: F, reverse: R) and hydrolysis probe (P) sequences used for RT-qPCR cytokine quantiﬁcation in the brains of dogs.
Target Primers and
probes
Sequence (5′ → 3′) Product size (bp) GenBank accession
number
Reference
G3PDH
F TCAACGGATTTGGCCGTATTGG
90 AB022763 Peters et al. (2005)R  TGAAGGGGTCATTGATGGCG
P CAGGGCTGCTTTTAACTCTGGCAAAGTGAA
IL-1
F TCTCCCACCAGCTCTGTAACAA
80 Z70047 Fujiwara et al. (2003)R GCAGGGCTTCTTCAGCTTCTC
P  CTGAGGCATTTCGTGTCAGTCATTGTAGCTT
IL-6
F CTCTCCACAAGCGCCTTCTC
102 U12234 Peters et al. (2005)R  TGAAGTGGCATCATCCTTGG
P TGGGGCTGCTCCTGGTGATG
IL-10
F CGACCCAGACATCAAGAACC
101 U33843 Peters et al. (2005)R  CACAGGGAAGAAATCGGTGA
P TCCCTGGGAGAGAAGCTCAAGACCC
IL-12p40
F CAGCAGAGAGGGTCAGAGTGG
109 AF091134 Peters et al. (2005)R ACGACCTCGATGGGTAGGC
P  TGGAGTGTCAGGAGGGCAGTGC
IFN-
F TCAACCCCTTCTCGCCACT
113 AF126247 Peters et al. (2005)R  GCTGCCTACTTGGTCCCTGA
P CCCCACCCGAACCTCTTCCT
TGF-
F CTGGAGTCGTGAGGCAGTG
96 L34956 Peters et al. (2005)R  GCAGTGTGTTATCTTTGCTGTCA
P TTTCGCCTCAGTGCCCACTG
F ACCCATGTGCTCCTCACC
a
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ccording to Livak and Schmittgen (2001) using G3PDH
glyceraldehyde-3-phosphate dehydrogenase) as a refer-
nce gene. The results are expressed as relative gene
xpression, which indicates how many times (fold change)
he gene expression of a cytokine is higher (up-regulated)
r lower (down-regulated) in the infected dogs when com-
ared with the control group.
.4. Brain histopathology
Brain hemispheres were placed in 10% buffered-
ormalin and were kept in this ﬁxative for a maximum of
4–48 h before being parafﬁn-embedded, sectioned (5 m)
nd stained with hematoxylin and eosin (HE) using rou-
ine protocols. The following brain areas were evaluated by
ight microscopy: cerebral cortex, thalamus, hippocampus,
ons-medulla oblongata, cerebellum, and the ventricular
horoid plexi and periventricular white matter.
.5. Splenic parasite load determination by qPCR
Total DNA was extracted from spleen samples weight-
ng ca. 25 mg  using the DNeasy blood & tissue kit
Qiagen, 69506) according to the manufacturer’s pro-
ocol. A standard curve was composed with L. infan-
um (Syn. chagasi) DNA (strain MHOM/BR/72/LD46)
xtracted from 1.6 × 107 promastigotes/mL using the phe-
ol:chloroform method and divided into seven serial
ilutions (1.6 × 105 until 1.6 × 10−1 promastigotes/mL).
he DNA was then quantiﬁed with a NanoDrop spec-
rophotometer (260/280 ratio between 1.8 and 2.0) and87 Z70046 –
frozen at −20 ◦C until further analyses. The selected
primer pair (forward: 5′-CCTATTTTACACCAACCCCCAGT-
3′; reverse: 5′-GGGTAGGGGCGTTCTGCGAAA-3′; GenBank
accession number Z35276) ampliﬁed a 116 bp fragment
of the minicircle kinetoplast DNA (kDNA) of Leishmania
(Ranasinghe et al., 2008). qPCR was  carried out in a real-
time thermocycler (Bio-Rad, CFX96) using SYBR green
Master Mix  (Sigma–Aldrich, S4438), 900 nM of each primer
and 5 L of DNA in a total volume of 25 L. The ampliﬁca-
tion conditions were the following: 94 ◦C for 2 min  and 40
cycles of 94 ◦C for 15 s and 60 ◦C for 1 min. Then, the sam-
ples were submitted to a melt curve from 60 ◦C to 95 ◦C,
with a 0.5 ◦C increase every 5 s.
2.6. Statistical analysis
For statistical analysis, all values were log-transformed.
For analyses involving comparisons between groups, the
values were derived from the equation 2−Ct. Signiﬁcant
differences between groups were determined by Student’s
t test, and correlations were evaluated with Pearson’s test.
Statistical signiﬁcance was  accepted when P < 0.05, and
changes were considered as trends when 0.05 < P < 0.1. All
statistical analyses were performed using Prism software
(Prism 5, GraphPad)
2.7. Ethical issuesThis study was  approved by the institutional Ethics and
Animal Welfare Committee (CEEA – Comissão de Ética e
Experimentac¸ ão Animal, UNESP, process #05/06).
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Table 2
Reaction efﬁciency values (E), determination coefﬁcients (r2) and angular
coefﬁcients (slope) of the RT-qPCRs of each evaluated gene.
Target E r2 Slope
G3PDH 99.8 0.956 −3.327
IL-1 99.9 0.976 −3.323
IL-6 96.5 0.983 −3.383
IL-10 99.9 0.981 −3.323
IL-12p40 98.5 0.971 −3.331
IFN- 99.1 0.969 −3.342
TGF- 96.9 0.992 −3.399
TNF- 97.2 0.989 −3.419
3. Results
3.1. Cytokine gene expression in the brain
With the selected primer pairs and hydrolysis probes,
it was possible to quantify the gene expression of the pro-
inﬂammatory cytokines IL-1, IL-6, IL-12p40, IFN-, and
TNF-, and the anti-inﬂammatory cytokines IL-10 and TGF-
. Values for reaction efﬁciency, slope and the r2 of each
evaluated gene are shown in Table 2. The levels of the
gene expression of each cytokine in both experimental
groups are shown in Table 3. Through the equation 2−Ct
it was possible to observe the pattern of the cytokines
expression in the infected dogs, when compared with the
control group (Fig. 1). In the brains of dogs with VL, IL-
1 expression was found to be signiﬁcantly up-regulated
by 8.04-fold, similarly to IFN-, by 5.85-fold, and to TNF-
, by 6.36-fold. The expressions of the anti-inﬂammatory
cytokines were signiﬁcantly down-regulated in the brains
of dogs with VL: IL-10 (6.08-fold less) and TGF- (5.25-fold
Fig. 1. Relative gene expression of cytokines in the brains of dogs with vis-
ceral leishmaniasis. The values were log-transformed and are expressed
as  fold changes. Positive values indicate up-regulation of gene expression
and negative values indicate down-regulation of gene expression as com-
pared to the control dogs. The normalization factor was  the reference gene
G3PDH according to the 2−Ct method. * Indicates P < 0.05.tology 192 (2013) 57– 66
less). There was  noticed a trend to the down-regulation
of the pro-inﬂammatory cytokine IL-12p40 (6.81-fold less)
in the brains of the infected dogs. Further, IL-6 expression
was  higher in the brains of dogs with VL (3.49-fold more)
although with no signiﬁcance.
To evaluate the interaction between different cytokines,
log-transformed values were subjected to Pearson’s cor-
relation analyses. Among the pro-inﬂammatory cytokines,
the expression of TNF- had a strong positive correlation
with IL-6 (P = 0.0041; r = 0.693; Fig. 2a) and moderate pos-
itive correlations with IL-1 (P = 0.0463; r = 0.489; Fig. 2b)
and IFN- (P = 0.0101; r = 0.605; Fig. 2c). IL-6 expression
exhibited a trend toward a moderate positive correlation
with IFN- (P = 0.0997; r = 0.412; Fig. 2d). In contrast, IL-
6 gene expression was  moderately negatively correlated
with IL-10 (P = 0.0142; r = −0.582; Fig. 2e); speciﬁcally, up-
regulation of IL-6 was  related to down-regulation of IL-10.
3.2. Splenic parasite load
Through the standard curve composed of seven serial
dilutions (105–10−1) of Leishmania DNA, it was  possi-
ble to quantify the amount of protozoan DNA in the
spleens of all infected dogs. This number ranged from
4.44 × 10−1 to 8.31 × 105 parasites/25 mg  of splenic tissue
(mean 5.32 × 104). None of the control dogs presented
positive ampliﬁcation. Ampliﬁcation reactions obtained an
efﬁciency value of 100% with a determination coefﬁcient
of r2 = 0.968 and a slope of −3.323. The melt curve indi-
cated the speciﬁcity of the primer pair selected, as only one
peak was present at 83.5 ◦C. To test whether the periph-
eral parasite load inﬂuenced cytokine gene expression in
the brain, log-transformed values of splenic parasite load
and cytokine gene expression were subjected to Pear-
son’s correlation analyses. No correlations were noted
between splenic parasite load and IL-1 (P = 0.3884), IL-6
(P = 0.1758), IL-10 (P = 0.8716), IL-12p40 (P = 0.6869), IFN-
(P = 0.2606), TGF- (P = 0.4029) or TNF- (P = 0.1716).
3.3. Brain histopathology
Histopathological analyses revealed inﬂammatory
alterations in the brain, especially regarding leukocyte
inﬁltration. Perivascular mononuclear cell inﬁltrates that
ranged in intensity from mild to severe were detected
in the leptomeninges, choroid plexus and periventricular
areas. Perivascular mononuclear cell inﬁltration was also
observed in the brain parenchyma, but with minimal to
moderate intensity (Fig. 3a–d). Nervous cell alterations
including the occurrence of satellitosis and neuronophagia
were also observed. Glial cell alterations were more evi-
dent, particularly in periventricular areas, with focal and
diffuse gliosis (Fig. 3e and f).
3.4. Macroscopic lesions
The main macroscopic alterations observed in the dogs
during necroscopic examination are reported in Table 4.
The most prevalent ﬁndings were cutaneous lesions (seb-
orrhea, periocular alopecia, generalized alopecia, nasal
planum hyperkeratosis, pododermatitis), ocular lesions
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Table 3
Cytokine gene expression in the brain of dogs. For each cytokine, individual values were normalized with the reference gene G3PDH using the equation
2−Ct. Values were then log-transformed and expressed as mean (±standard deviation).
Cytokine Group Relative expressiona P-value
Infected Control
IL-1 −4.09 (±0.47) −4.90 (±0.58) ↑ 0.0020*
IL-6 −4.44 (±1.06) −4.79 (±0.89) ↑ 0.4801
IL-10  −4.17 (±0.55) −3.57 (±0.72) ↓ 0.0383*
IL-12p40 −4.45 (±0.96) −3.77 (±0.91) ↓ 0.0918
IFN- −3.93 (±0.79) −4.94 (±1.11) ↑ 0.0238*
TGF- −2.62 (±0.41) −2.10 (±0.39) ↓ 0.0106*
TNF- −4.32 (±0.74) −5.24 (±0.66) ↑ 0.0174*
* Indicates P < 0.05.
a Cytokine expression in the infected dogs in comparison with the control dogs. ↑: up-regulation; ↓: down-regulation.
Fig. 2. Correlations between cytokine gene expression in the brains of dogs with visceral leishmaniasis. The scatter plots indicate the positive correlation
between TNF- and IL-6 (a; P = 0.0041), TNF- and IL-1 (b; P = 0.0463), TNF- and IFN- (c; P = 0.0101), the trend toward a positive correlation between IL-6
and  IFN- (d; P = 0.0997) and the negative correlation between IL-6 and IL-10 (e; P = 0.0142). The least squares equation and the coefﬁcient of determination
(r2) are shown on the plots. All values were log-transformed.
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Fig. 3. Representative photomicrography of brain alterations in dogs with visceral leishmaniasis. (a) Intense perivascular lymphoplasmacytic inﬁltration
(arrow)  in cortical leptomeninge. (b) Perivascular lymphoplasmacytic inﬁltration (arrow) in the choroid plexus from the lateral ventricle. (c) Mononuclear
perivascular cuff (arrow) in the piriform cortex. (d) Mononuclear perivascular inﬁltration (arrow) in the subependymal area with no alteration of the ependy-
l area. (f
 highligmal  layer (arrowhead). (e) Focal glial nodule (arrow) in the subependyma
microglial cells (arrowhead). Inset: high magniﬁcation of a microglial cell
Eosin.  Scale bar = 100 m (a), 50 m (b, c, e, f), 20 m (d).
(conjunctivitis, blepharitis, ocular discharge), generalized
lymphadenopathy and emaciation/cachexia. There were no
signs of macroscopic brain lesions.
Table 4
Macroscopic alterations observed during the necroscopic examination of
the dogs.
Macroscopic alteration Infected (n = 19) Control (n = 6)
n % n %
Brain alterations – – – –
Cutaneous lesions 11 57.9 – –
Emaciation/cachexia 6 31.6 – –
Evident splenic white pulp 3 15.8 – –
Hepatosplenomegaly 4 21.1 – –
Lymphadenopathy 11 57.9 – –
Ocular lesion 9 47.4 – –
Onycogryphosis 7 36.8 – –
Other 3 15.8 – –
No alteration 3 15.8 6 100.0) Diffuse microgliosis in the subependymal area. Note the high number of
hting an elongated nucleus with a rod shape (rod cell). Hematoxylin and
4. Discussion
The main histopathological lesions found in the brain of
the dogs were related to leukocyte inﬁltration and glial cells
activation. Meningitis and choroiditis are well described
in dogs with VL (Nieto et al., 1996; Vin˜uelas et al., 2001;
Melo et al., 2009; Melo and Machado, 2009). Vasculitis is a
widespread condition found in dogs with VL primarily due
to immune complex deposition with consequent comple-
ment activation; in the SNC this condition may  lead to the
occurrence of brain and spinal cord infarctions (Font et al.,
2004; José-López et al., 2012). Similar inﬂammatory and
ischemic lesions were also described in human and murine
cerebral malaria (Penet et al., 2005; Turner, 1997), in feline
toxoplasmosis (Dubey et al., 1996) and in the human co-
infections toxoplasmosis/HIV (Ibebuike et al., 2012) and
Chagas disease/HIV (Madalosso et al., 2004).
In order to associate the histopathological alterations
with a “inﬂammatory status”, it was  decided to determine
the cytokine proﬁle expressed in the brains of dogs with
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L. Consequently, it was possible to detect and quantify
he expression of the pro-inﬂammatory cytokines IL-1,
L-6, IL-12p40, IFN- and TNF- and the anti-inﬂammatory
ytokines IL-10 e TGF- in the brains of dogs by RT-qPCR.
In the brains dogs with VL, up-regulation of the expres-
ion of IL-1 and TNF- were noted, as well as a slight
ncreased expression of IL-6. These are the main cytokines
bserved in the CNS during inﬂammation and are related
o fever, defense against pathogens and induction of the
roduction of other cytokines (de Vries et al., 1997). A
ositive correlation between the expression of the pro-
nﬂammatory cytokines IL-1, IL-6, IFN- and TNF- was
lso detected, which supports the notion of a relationship
etween the biosynthesis of these cytokines and illustrates
he intricacy and redundancy of the immune response in
he CNS.
More speciﬁcally, one key feature of the inﬂammatory
rocess in the CNS is the integrity of the blood–brain bar-
ier (BBB). IL-1 is considered the most important cytokine
cting in BBB breakdown, along with TNF- and IL-6, which
ct by increasing the expression of adhesion molecules in
he endothelium. This enables leukocyte trafﬁc into the
rain (Abbott et al., 2006; de Vries et al., 1996; Hickey,
999; Quagliarello et al., 1991). Evidence supporting the
ction of IFN- across the BBB has also been reported. It
as been shown that brain microvascular endothelial cells
ncubated with IFN- suffer morphological and organiza-
ional changes that enable permeability alterations and
ncrease MHC  class II expression (Huynh and Dorovini-
is, 1993). Further, high levels of systemic IFN- has been
escribed in VL, however, this increase was not related to
arasite control, but with disease chronicity, probably due
o a defective intracellular signaling and low expression of
FN- receptors (Ansari et al., 2006).
The integrity of the BBB is not only affected by fac-
ors that disrupt it but also by the lack of components
hat support its integrity. TGF- is related to BBB integrity
hrough the maintenance of the tight junctions between
he endothelial cells (Dohgu et al., 2004) and by the contin-
ous production by the BBB’s pericytes (Dohgu et al., 2005).
urther, regarding the role of pericytes, these cells are
ensitive to TNF- and release matrix metalloproteinase
 (MMP-9), one important proteolytic enzyme related to
BB disruption (Takata et al., 2011). TNF- was  found
p-regulated in the brain and because the presence of
MP-9 has already been described in cerebrospinal ﬂuid
CSF) and in brains of dogs with VL (Machado et al., 2010;
arangoni et al., 2011), we hypothesize that Leishmania
nfection promotes a dysregulation of the BBB’s selective
ermeability, with later leukocyte inﬁltration. MMP-9 was
lso up-regulated following an in vitro treatment with IL-
/TNF- in choroid plexus epithelium cultures (Strazielle
t al., 2003), an important structure through which lym-
hocytes migrate into the nervous milieu (Petito and
dkins, 2005).
The histopathological brain alterations in the dogs
ith VL might also be secondary to the action of
ro-inﬂammatory cytokines, such as IFN-, which have
reviously been related to in vitro astrocyte proliferation
nd gliosis in the mouse brain (Yong et al., 1991), simi-
ar to what occurs in the brain of dogs with VL (Melo andtology 192 (2013) 57– 66 63
Machado, 2011). On the other hand, the lack of neuropro-
tective factors such as IL-10 and TGF- may also contribute
to brain lesions. IL-10 inhibits cytokine production and
cytokine receptor expression in microglial cells (Sawada
et al., 1999), and IL-10 knock-out mice were more suscepti-
ble and did not have spontaneous recovery in experimental
autoimmune encephalomyelitis (Samoilova et al., 1998).
Regarding TGF-, which is considered an anti-
neurodegenerative agent, studies with knock-out mice
revealed the ability of this cytokine to maintain neu-
ronal integrity and survival, and regulate microglial activity
(Brionne et al., 2003). The down-regulation of TGF- gene
expression provides further evidence for elucidation of the
histopathological alterations observed, and corroborates
the results from previous studies concerning microglial
activation in the brain of the dogs with VL (Melo and
Machado, 2011).
Surprisingly, the expression of the pro-inﬂammatory
cytokine IL-12p40 tended to be diminished in the brains
of dogs with VL. A possible explanation of this diminish-
ment may  be the negative feedback relationship with the
action of other cytokines, such as TNF- and type-I IFN, or
even other inﬂammatory mediators, such as prostaglandin
E2, components of the complement system, and immune
complexes (Ma et al., 2000; Ma,  2001; McRae et al., 1998).
Moreover, within the CNS, the main IL-12 producers are
microglia, and interaction with other cells may  interfere
with its ability to produce this cytokine. In vitro, microglial
cells stimulated with lipopolysaccharide (LPS)/IFN- pro-
duced high amounts of IL-12p40 and IL-12p70; however,
in microglial and astroglial co-cultures, and in microglial
cultures with added astroglial-conditioned medium, the
detection of both of IL-12p40 and IL-12p70 presented sig-
niﬁcant decreases (Aloisi et al., 1997). Since IL-12 is a key
Th1 polarizing cytokine (Watford et al., 2003) the dimin-
ishment of this cytokine may  indicate a lack of ability to
mount an effective immune response against Leishmania
infection (Mattner et al., 1996), especially regarding the
nervous milieu, but strongly suggests that leukocyte inﬁl-
tration into the brain during VL is not dependent of this
cytokine.
Among the main neurological symptoms reported
in dogs with VL is the occurrence of seizures (Ikeda
et al., 2007; Melo et al., 2012). Recently, inﬂamma-
tion and BBB disruption have been considered major
causes of epileptogenesis (Choi and Koh, 2008; Vezzani
and Granata, 2005), and the occurrence of spontaneous
seizures has been associated with reactive gliosis and neu-
ronal/astroglial degeneration (Borges et al., 2003; Choi
and Koh, 2008; Vezzani and Granata, 2005). Furthermore,
microglial expression of a variety of cytokines, such as IL-
1, IL-2, IL-6, IFN-, TNF- and GM-CSF has been related to
astrogliosis; and because astrocytic hypertrophy deregu-
lates glutamate absorption by astrocytes, astrogliosis may
predispose to the occurrence of seizures (Hanisch, 2002;
Choi and Koh, 2008).
To the authors’ knowledge, this is the ﬁrst study that
evaluates the brain cytokine proﬁle of dogs with VL. The
brain cytokine proﬁle is rather similar to comparative anal-
yses with other protozoan diseases. Rats infected with
Trypanosoma brucei exhibited high levels of IL-1 and
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TNF- mRNA in the brain (Quan et al., 1999). In mouse
toxoplasmic encephalitis, increased IL-1 and also IL-
10 (Schlüter et al., 1997) has been observed. Astrocytes
infected with Toxoplasma gondii produced IL-1, IL-6 and
GM-CSF, while microglia produced TNF- and TGF- con-
comitantly (Fischer et al., 1997). In murine cerebral malaria,
increased IL-1, IFN- and TNF- gene expression have
been reported, but no alterations in IL-2, IL-4, IL-5, IL-
6, IL-10, IL-12 or GM-CSF have been described (Jennings
et al., 1997). Further, cerebral-malaria-susceptible mice
expressed lower levels of IL-10 in the brain (Kossodo
et al., 1997), and in human cases of cerebral malaria, high
immunohistochemical detection of TGF-1, 2 and 3 has
been observed (Deininger et al., 2000). Despite the occur-
rence of an immune activation status in the CNS of patients
with these diseases, the cytokine proﬁles are dissimi-
lar, especially concerning the anti-inﬂammatory cytokines.
This dissimilarity may  be due to differences inherent to
each pathogen and the absence of Leishmania in the nervous
environment, unlike that which occurs with Plasmodium,
Toxoplasma and Trypanosoma.
To date, there is not enough evidence of Leishmania
entry into the CNS (Nieto et al., 1996; Vin˜uelas et al., 2001),
and several studies failed the attempt to detect the par-
asite in the brain (Ikeda et al., 2007; Melo and Machado,
2009, 2011). Therefore, the inﬂammatory alterations in the
brains of dogs with VL are considered to be a consequence
of the peripheral immune stimuli and the immune complex
deposition and circulating antigens (Garcia-Alonso et al.,
1996; Ikeda et al., 2007).
When the BBB selective ﬁltration is compromised, the
passage of inﬂammatory mediators and immunoglobulins
is allowed (Diamond et al., 2009). It is known that lym-
phocytes, macrophages, mast cells, as well as microglia,
astrocytes, oligodendrocytes and also neurons possess
receptors for the Fc portion of the immunoglobulins. The
activation of these receptors initiates a series of biolog-
ical responses including phagocytosis, degranulation and
cytokine genes activation (Nimmerjahn and Ravetch, 2008;
Okun et al., 2010). High titers of anti-Leishmania antibodies
in the CSF have already been described in dogs with natu-
ral VL (Garcia-Alonso et al., 1996; Lima et al., 2003; Ikeda
et al., 2007; Melo et al., 2009), and, therefore, the pres-
ence of circulating antibodies within the nervous milieu
may  contribute to the beginning and to the maintenance
of an inﬂammatory process, as described in other immune
and degenerative diseases of CNS (Seiwa et al., 2007; Deane
et al., 2009).
The CNS response to peripheral stimuli is well described
in experimental animals. Peripheral LPS administration
in mice promotes IL-1, IL-6 and TNF- gene expres-
sion in the spleen and brain with distinct expression
patterns (Layé et al., 1994). Furthermore, in rats that
received peritoneal LPS administration, up-regulation of
IL-1 gene expression in the brain was observed, and
the ﬁrst brain regions to present the expression of this
cytokine were the choroid plexus, the circumventricu-
lar organs and the leptomeninges (Quan et al., 1998).
Despite using LPS as an experimental model, these studies
provide additional support for the hypothesis that periph-
eral stimuli, such as Leishmania infection, may promotetology 192 (2013) 57– 66
alterations in the nervous milieu and also provide support
for the concept of immune response compartmental-
ization, in which different organs and tissues produce
speciﬁc and distinct immune responses following the same
stimulus (Alexandre-Pires et al., 2010; Reis et al., 2009).
Cytokine proﬁle patterns in dogs with VL have been
described in the spleen, liver, lymph nodes, bone marrow,
peripheral blood mononuclear cells (PBMC) and skin. In
all these cases, dissimilarities were observed based on the
organ/tissue studied and the clinical stage of the disease
(Barbosa et al., 2011; Chamizo et al., 2005; Manna et al.,
2006; Menezes-Souza et al., 2011; Panaro et al., 2009; Reis
et al., 2009; Santos-Gomes et al., 2002).
In the data presented here, we  observed an up-
regulation of IL-1, IFN- and TNF- gene expression and
a down-regulation of IL-10 and TGF- gene expression in
the brains of dogs with VL. IL-12p40 presented a trend to
down-regulation and IL-6 presented no signiﬁcant differ-
ence. Altogether, these data indicate a pro-inﬂammatory
environment in the CNS of dogs with VL and suggest
that the brain alterations are related to the expressed
cytokine proﬁles because cytokines such as IL-1 and TNF-
 are considered key factors for the initiation, maintenance
and persistence of inﬂammation. The lack of correlations
between cytokines and peripheral parasite load suggests
that the brain alterations are due to the host’s immune
response regardless of the phase of the disease and cor-
roborate other studies reporting T lymphocyte inﬁltration
(Melo et al., 2009), glial activation (Melo and Machado,
2011), the presence of MMP-2 and MMP-9 in the CSF
(Marangoni et al., 2011), and MMP-9 in the nervous tissue
(Machado et al., 2010).
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